Additionally, CXCL13, a chemokine associated with B-cell trafficking, and CCL23, which recruits monocytes and other immune cells, have been identified as potential biomarkers of disease activity in RA patients [85]. This evidence concerns the gene CXCL13 and rheumatoid arthritis.